FIELD: medicine.
SUBSTANCE: viral hepatitis in simulated in laboratory animals (rats) with D-galactosamine. Hepatitis is treated by single oral administration of immobilised hyaluronidase 25 unit/kg. Administration either precedes simulation, or is combined with the beginning of stimulation.
EFFECT: method enables reducing a severity of metabolic and morphological hepatic disorders effectively in stimulating hepatitis identical to viral hepatitis in a human with underlying reduced xenobiotic load on the body.
1 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| HEPATOPROTECTOR | 2010 |
|
RU2444569C1 |
| EXPERIMENTAL TOXIC CHRONIC HEPATITIS TREATMENT METHOD | 2009 |
|
RU2392000C1 |
| METHOD FOR STIMULATING MYELOGENESIS | 2010 |
|
RU2442589C1 |
| METHOD FOR TREATING EXPERIMENTAL CHRONIC TOXIC HEPATITIS | 2005 |
|
RU2295971C1 |
| DRUG POSSESSING REGENERATIVE ACTIVITY | 2011 |
|
RU2480236C1 |
| MEDICATION FOR REGENERATIVE MEDICINE | 2009 |
|
RU2406528C2 |
| METHOD OF INCREASING STEM CELLS MOBILIZATION | 2009 |
|
RU2442601C2 |
| METHOD OF STIMULATING LIVER STEM CELL DIFFERENTIATION IN VITRO IN TISSUE-SPECIFIC DIRECTION | 2012 |
|
RU2477752C1 |
| APPLICATION OF L-LYSINE TIAZOTOTATE AS AN ACTIVE BASIS FOR MEDICINES OF HEPATOPROTECTIVE AND DETOXICATIVE ACTION | 2018 |
|
RU2679447C1 |
| INDIVIDUAL SUBSTANCES SYNTHESIZED ON BASE OF CHEMICAL INTERACTION OF DISULFIDE-CONTAINING PEPTIDES WITH PURINE OR PYRIMIDINE BASE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND PREPARATIONS BASED ON THEREOF, METHODS OF THEIR USING FOR TREATMENT OF INFECTIOUS DISEASES AND PROPHYLAXIS OF COMPLICATIONS | 2001 |
|
RU2178710C1 |
